文献速递MDS 与骨髓增殖性肿瘤

骨髓增生异常、骨髓增殖及骨髓增生异常/骨髓增殖性肿瘤的分类:过去、现在与未来

Classification of Myelodysplastic, Myeloproliferative, and Myelodysplastic/Myeloproliferative Neoplasms: The Past, Present, and Future.
PubMed 文献 · Am J Hematol · 2025-03-08

本文综述骨髓增生异常、骨髓增殖及骨髓增生异常/骨髓增殖性肿瘤分类的演变,回顾早期对慢性髓系疾病的认识及临床观察与细胞学、组织学、免疫表型乃至遗传学特征的结合,说明分类是持续演进的过程,需不断更新。

要点

  • 综述梳理髓系肿瘤分类从临床观察到细胞、组织、免疫表型及遗传学特征结合的历史演变。
  • 慢性髓系肿瘤的联合分类方法定义了临床病理疾病实体,使治疗更个体化。
  • 疾病分类是持续演进的过程,需随认识加深不断更新。

核心结论

  • 疾病分类是持续演进的过程,需随对诊断和治疗疾病认识的加深不断更新。

研究设计与样本

  • 本文为综述,围绕新近发表的造血肿瘤分类系统,回顾髓系肿瘤疾病实体的认识与正式分类的发展。

主要发现

  • 早期对髓系疾病尤其是慢性髓系疾病的认识,使临床观察逐步与特定细胞学、组织学、免疫表型乃至遗传学特征相关联。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With the recent publication of new classification systems of hematopoietic neoplasms, understanding how recognition of disease entities has occurred over time and the subsequent development of formal disease classifications is of importance. This review focuses on the early recognition of myeloid disorders, especially chronic myeloid disorders, and how clinical observations became associated with specific cytologic, histologic, immunophenotypic, and eventually genetic features. This combined approach to disease classification is of particular importance in the evaluation of chronic myeloid neoplasms and has resulted in the definition of clinicopathologic disease entities that allow for more customized treatment approaches. The constant incorporation of ever-increasing information related to these disorders illustrates that disease classification is a constantly evolving process that requires constant updates as we strive to better understand the disorders we diagnose and treat.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Arber DA, Orazi A. Classification of Myelodysplastic, Myeloproliferative, and Myelodysplastic/Myeloproliferative Neoplasms: The Past, Present, and Future. Am J Hematol. 2025. PMID: 40056065. doi:10.1002/ajh.27656

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。